Mefenamic acid plays a key role in the relief of symptoms of mild to moderate pain, including menstrual pain, in the area of pain management. The blog will focus on the manufacturing process, API manufacturing companies, future prospects and government initiatives regarding mefenamic acid.
Mefenamic acid is a nonsteroidal anti-inflammatory medicine (NSAID) that belongs to the anthranilic acid derivatives class. It's a pain reliever for mild to moderate pain, such as menstrual cramps and headaches. It's working by reducing the hormones that cause inflammation and pain in the body.
For the treatment of conditions such as menstrual pain, headache, muscle pain, joint pain, and dental pain, mefenamic acid is primarily used. It's sometimes used for the prevention of migraines caused by menstrual bleeding.
A complex pharmaceutical manufacturing process is used to produce Mefenamic Acid. In order to ensure both safety and effectiveness, the essential components are manufactured through chemical processes in conjunction with strict quality control procedures.
Mefenamic acid is produced by a number of API manufacturing companies. Some of these industries are as follows:
• Jai Radhe Sales: Jai Radhe Sales is a partner in all procurement needs.
• Zeon Pharma Industries India Pvt Ltd: Zeon produces and supplies APIs and intermediates.
• Tagoor Laboratories: High quality APIs are offered thanks to Tagoor GmbH's expertise in product development, supported by a comprehensive understanding of the processes.
• Nira Life Sciences Pvt. Ltd.: The largest producer and exporter of mefenamic acid is Nira Life Sciences with a production capacity of 900 MT/Annum.
A thorough examination of both established and new players in the market is presented here. The wide range of best companies are categorised according to the type of products they offer, as well as by different market related factors. Some of the prominent companies in this market are: -
• Shionogi Pharma
• Solitaire Pharmacia
• Shinto Organics
• Captab
• EMS Pharma
• Latest News
• Mankind
• Pfizer
• Daiichi Sankyo
• Chemidex Pharma
• Recently, the Indian Pharmacopoeia Commission (IPC) issued a drug safety alert about Meftal, a commonly used non-steroidal anti-inflammatory drug (NSAID), saying that its ingredient, mefenamic acid, triggers Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, a severe allergic reaction.
• This was revealed after a preliminary analysis was conducted on adverse drug reactions by the Pharmacovigilance Programme of India (PvPI).
In tumor bearing mice, mefenamic acid showed potential as a promising therapeutic agent against colon cancer. This suggests that Mefenamic Acid might have future applications in the treatment of colon cancer, expanding its use beyond pain management. However, the full understanding and validation of these potential benefits requires further research.
Chemxpert Database, a top pharmaceutical database company in lifescience industries. It provides information on buyers, suppliers, regulatory conditions, patents, warnings, clinical studies and many others related to mefenamic acid.
In a sector with growing demand, mefenamic acid is an important component of the pharmaceutical industry. However, it is important to be aware of the potential side effects as with all medicines. If you have a history of Gastrointestinal, Cardiovascular or Renal Diseases, consult your healthcare professional before initiating or continued mefenamic acid treatment.